A case of aripiprazole and tardive dyskinesia

J Psychopharmacol. 2009 Mar;23(2):214-5. doi: 10.1177/0269881108089591. Epub 2008 May 30.


This is a case report of a 24-year-old African lady, who developed symptoms of tardive dyskinesia (TD) following 9 months of treatment with aripiprazole 15 mg. She has no family history of mental illness, not used illicit substances and has a medical diagnosis of idiopathic hypertension which is well controlled. The patient has an 18-month history of paranoid schizophrenia with three psychotic episodes, one severe enough to warrant admission. Upon discontinuation of aripiprazole and switch to quetiapine, the symptoms of TD disappeared rapidly. A PubMed search revealed one previous case report of aripiprazole and TD. The authors recommend maintaining vigilance regarding all possible side-effects irrespective of the type of antipsychotic being used.

Publication types

  • Case Reports

MeSH terms

  • Antipsychotic Agents / administration & dosage
  • Antipsychotic Agents / adverse effects*
  • Antipsychotic Agents / therapeutic use
  • Aripiprazole
  • Dyskinesia, Drug-Induced / etiology*
  • Female
  • Humans
  • Piperazines / administration & dosage
  • Piperazines / adverse effects*
  • Piperazines / therapeutic use
  • Quinolones / administration & dosage
  • Quinolones / adverse effects*
  • Quinolones / therapeutic use
  • Schizophrenia / drug therapy
  • Young Adult


  • Antipsychotic Agents
  • Piperazines
  • Quinolones
  • Aripiprazole